Local immunity and microflora of the reproductive tract of gynecological patients before and after immunomodulatory therapy.
| Autor: | Zherebyateva OO; The Orenburg state medical university of Minzdrav of Russia., Makhalova GO; The Orenburg state medical university of Minzdrav of Russia., Kirgizova SB; The Orenburg state medical university of Minzdrav of Russia., Kshnyaseva SK; The Orenburg state medical university of Minzdrav of Russia., Mironov AY; The G.N. Gabrichevskiy Moscow research institute for epidemiology and microbiology of Rospotrebnadzor., Mikhailova EA; The Orenburg state medical university of Minzdrav of Russia. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2021 Mar 30; Vol. 66 (3), pp. 177-180. |
| DOI: | 10.51620/0869-2084-2021-66-3-177-180 |
| Abstrakt: | Immunomodulatory drugs are widely used as drugs for the treatment of inflammatory diseases of microbial etiology in clinical medicine. The authors evaluated the effectiveness of the therapeutic effect of the Cycloferon immunomodulator in the treatment of chronic purulent-inflammatory diseases of the reproductive tract using clinical, microbiological and immunological parameters. It was shown that under the influence of immunomodulatory therapy, the restoration of the qualitative and quantitative composition of the normoflora was observed with the elimination of etiologically significant microorganisms. The immunocorrective effect of therapy on the indices of local immunity was established: the concentration of lactoferrin increased in the cervical secretion, the level of cytokines IL-1β and γ-IFN normalized, the amount of secretory IgA increased significantly, which contributed to the enhancement of local protective reactions, as well as the clinical efficacy of therapy, which was manifested in the reduction and/or disappearance of pain syndrome and the absence of relapse for 2 or more years. Conducted researches allow us to speak of immunotropic drugs as a promising direction in the treatment of inflammatory processes of the reproductive tract, a significant advantage of which is rational immunomodulation directly in the focus of inflammation, the availability of treatment, the absence of side effects with adequate therapeutic regimens, which makes it relevant to further study this direction of immunocorrection and its implementation into wide clinical practice. Competing Interests: The authors declare no conflict of interest. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|